DGAP-News: MeVis Medical Solutions AG / Key word(s): Final Results MeVis Medical Solutions AG: MeVis publishes figures for fiscal year 2015 and guidance for 2016 22.04.2016 / 13:30 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Revenues increased by 22 %, earnings per share of EUR 3.76 (after EUR 2.16 in 2014) - Revenues increased by 22 % year on year to EUR 16.0 m - Earnings before interest an taxes (EBIT) increased by EUR 0.6 m to EUR 4.5 m - Net income rose by EUR 3.0 m to EUR 6.7 m - Liquidity increased by EUR 8.1 m to EUR 25.6 m - Guidance for 2016: - Decline in revenues to EUR 14.5 m to EUR 15.0 m - Decrease of EBIT to EUR 2.5 m to EUR 3.0 m Bremen, April 22, 2016 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, today announced its figures for fiscal year 2015. Revenues in 2015 increased significantly by 22 % (EUR 2.9 m) to EUR 16.0 m. However, the largest part of this increase (EUR 2.3 m) was attributable to a stronger US dollar; In addition, services made a EUR 0.5 m contribution to the revenue increase due, first and foremost, to the new cooperation agreement with Hologic. As a result, the licensing and maintenance business grew by just EUR 0.1 m when adjusted for currency effects. The increase in revenues is almost entirely attributable to the Digital Mammography segment, where sales to Hologic rose from EUR 9.8 m to EUR 12.6 m, whereas revenues in the Other Diagnostics segment increased only slightly, from EUR 3.3 m to EUR 3.4 m, despite the stronger US dollar. Operating costs rose in 2015. Staff costs increased, as planned, by EUR 0.4 m to EUR 7.4 m, and other operating expenses rose by EUR 0.7 m to EUR 2.7 m, mainly on account of higher legal and consulting costs in connection with the takeover offer and the domination and profit and loss transfer agreement with VMS Deutschland Holdings GmbH. Development costs were capitalized for the last time in the fourth quarter of 2014. As a result, they no longer contributed to the result in 2015, following income of EUR 1.2 m in 2014. Depreciation and amortization increased slightly by EUR 0.2 m to EUR 1.9 m in 2015. For the fiscal year this led to a EUR 0.6 m increase in EBIT (earnings before interest and taxes) to EUR 4.5 m, which corresponds to a still attractive EBIT margin of 28 % (prev. year 30 %). The financial result declined by EUR 0.6 m year on year to EUR 0.5 m, mainly due to the deterioration in the result from exchange rate differences. Tax income amounted to EUR 1.8 m in 2015 (in 2014 tax expenses of EUR 1.2 m). The reason for this rise was the release of deferred tax liabilities due to the fiscal unity for income tax purposes becoming effective in 2016. As a result, after-tax earnings rose strongly from EUR 3.7 m to EUR 6.7 m, which is equivalent to undiluted earnings per share of EUR 3.76 (after EUR 2.16 in 2014). In the fiscal year, cash and cash equivalents again saw a strong increase, of EUR 8.1 m to EUR 25.6 m, on the back of a strong operating development and the disposal of treasury stock to VMS Deutschland Holdings GmbH for EUR 1.7 m. "2015 was economically for us another very successful year. Our dependency on Hologic has, however, increased even further, which is reflected in a share of 78 % of total revenues in the past fiscal year." said Dr. Robert Hannemann, CFO of MeVis Medical Solutions AG." He added: "For 2016, we expect a slight decline in revenues to EUR 14.5 m to EUR 15.0 m, mainly from the existing business with Hologic. For most of the year 2017 this existing business should still continue, although we expect a significant decline in business with Hologic by the end of 2017 and in 2018." "We are facing bigger challenges in the future. In addition to the very large dependency on Hologic, the market for our products for lung cancer screening has not been developed as quickly as widely expected. Moreover, we continue to see a trend in the market toward fully integrated applications of the PACS suppliers, making it increasingly difficult for us to convince clinical end users of the added value of our dedicated specialized software solutions." added Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. "We remain confident that we are well prepared to meet future challenges. Contributing to this are mainly our experienced, highly qualified employees and the perspective cooperation with Varian Medical Systems." The interim financial statement for the first quarter 2016 will be published on May 24, 2016. --------------------------------------------------------------------------- 22.04.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone: +49 421 224 95 0 Fax: +49 421 224 95 999 E-mail: ir@mevis.de Internet: http://www.mevis.de ISIN: DE000A0LBFE4 WKN: A0LBFE Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 456921 22.04.2016
DGAP-News: MeVis Medical Solutions AG: MeVis publishes
Top 10 Most Recent News Articles
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus
A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...
Continue Reading
Four Data Quality Champions Put Trust on the Board
A single rotten customer record can gum up an entire operation faster than most executives care to admit. Bad data does not merely make a dashboard look silly; it can foul forecasts, duplicate work, misdirect automation, and leave an AI project confidently spouting nonsense. That is why Infotech's 2026 Data Quality Emotional Footprint report deserves a look, even if...
Continue Reading
APEC's Shenzhen Signal Is Bigger Than a Two-Day Summit
Shenzhen spent two days trying to turn regional anxiety into a workable agenda. The APEC CEO Summit 2026, held November 17 and 18 at the Qianhai International Convention Center, brought together more than 2,000 political and business leaders from all 21 APEC economies and 13 economies outside the group. That is a serious room, not a ceremonial photo line. Still, investors...
Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet
Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...
Continue Reading
Six LIFE Photographers Bring History Into Florida Focus
Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...
Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes
A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...
Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace
A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...
Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle
Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...
Continue Reading
Milwaukee County Contract Tests Wisconsin Labor Shift
A unanimous first contract in a Milwaukee County department is not the sort of headline that rattles a trading screen, but it can tell you plenty about where the ground is moving. Public safety workers in the county Facilities Department have ratified their first agreement with Teamsters Local 344, according to the union. The vote matters less for any disclosed economic...
Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too
A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...
Continue Reading